Literature DB >> 15886635

Oncologic and functional results of supracricoid partial laryngectomy with cricohyoidopexy.

Yucel Akbas1, Alp Demireller.   

Abstract

OBJECTIVE: Supracricoid partial laryngectomy with cricohyoidopexy (SPL-CHP) is an alternative technique described for extensive tumors of the larynx that are beyond the limits of classical conservation partial laryngectomy and otherwise would be treated by total laryngectomy. STUDY DESIGN AND
SETTING: Forty-six patients with carcinoma of the larynx underwent SPL-CHP between 1991 and 2003. The median age was 54 (range, 37 to 72). In 28 cases both arytenoids were spared; in 17 cases, 1 arytenoid was spared; and in 1 case, 2 arytenoids were resected. Bilateral elective neck dissections were performed in supraglottic carcinomas. In glottic carcinomas, neck dissection was performed in the presence of clinically positive lymph nodes. None of the patients were treated with postoperative radiation therapy.
RESULTS: Forty-five patients were successfully decannulated; 1 patient with 2 arytenoids resected could not tolerate decannulation. The mean time for decannulation was 20 days (range, 9 to 60 days) when both arytenoids were spared with SPL-CHP, and 41 days (range, 13 to 150 days) for SPL-CHP when 1 arytenoid was spared. The average time for removal of the feeding tube was 21 days (range, 9 to 60 days) when both arytenoids were spared, and 40 days (range, 16 to 127 days) when 1 arytenoid was spared. The removal time of the feeding tube of the patient with 2 arytenoids resected was postoperative day 63. In 2 patients, aspiration pneumonia occurred as a result of swallowing impairment. In none of the patients temporary or permanent gastrostomy was needed. Two patients had local recurrence and were treated with a total laryngectomy; they are still alive. In 2 patients, secondary primary tumors were detected. The 3-year overall and cause-specific actuarial survival rates were 95.7 % and 87.5 % , respectively.
CONCLUSIONS: Although prolonged hospitalization and delaying physiological functions can be termed as disadvantages of SPL-CHP, the operation is a reliable and oncologically valid procedure in selected cases of cancer of the larynx who would otherwise be operated by total laryngectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15886635     DOI: 10.1016/j.otohns.2005.01.030

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

Review 1.  Functional outcomes after supracricoid laryngectomy: what do we not know and what do we need to know?

Authors:  Antonio Schindler; Nicole Pizzorni; Francesco Mozzanica; Marco Fantini; Daniela Ginocchio; Andy Bertolin; Erika Crosetti; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

2.  Supracricoid laryngectomy with cricohyoidopexy: oncological results.

Authors:  Ilhan Topaloğlu; Muhlis Bal; Ziya Salturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

3.  Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation.

Authors:  Andressa Silva de Freitas; Izabella C Santos; Cristina Furia; Rodrigo Dornelas; Ana Catarina Alves E Silva; Fernando Luiz Dias; Gil F Salles
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-04       Impact factor: 2.503

4.  Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.

Authors:  Giorgio Peretti; Cesare Piazza; Francesca Del Bon; Renzo Mora; Paola Grazioli; Diego Barbieri; Stefano Mangili; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

Review 5.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

Review 6.  Limitations and Opportunities in Open Laryngeal Organ Preservation Surgery: Current Role of OPHLs.

Authors:  Giovanni Succo; Erika Crosetti
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.